Epigral Q2 FY27 Results: Consolidated Net Profit ₹65.08 Crore on Total Income of ₹752 Crore
- Earnings
- Chloro alkali and derivatives
Reviewed byKeshav SehgalBlacklitt Research
Epigral (NSE: EPIGRAL) reported consolidated total income of ₹751.81 crore and net profit of ₹65.08 crore for the quarter ended 30 Sep 2026, and standalone total income of ₹751.81 crore and net profit of ₹64.42 crore, it said in a filing on 02 Nov 2026. The results were approved by the board on 2 Nov 2026.
Key highlights
Consolidated
Including its subsidiaries
- Total income: ₹751.81 crore, up 27.6% YoY and 6.0% QoQ
- Net profit and EPS: ₹65.08 crore, up 27.1% YoY and down 34.8% QoQ; basic EPS ₹15.09
- Finance costs: ₹10.78 crore, down 50.6% YoY from ₹21.84 crore
- Other income: ₹5.82 crore, up 234.5% YoY
Standalone
The company on its own, without its subsidiaries
- Total income: ₹751.81 crore, up 27.6% YoY and 6.0% QoQ
- Net profit and EPS: ₹64.42 crore, up 25.0% YoY and down 35.0% QoQ; basic EPS ₹14.93
- Finance costs: ₹10.78 crore, down 50.6% YoY from ₹21.84 crore
Summary
| Particulars | Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ |
|---|---|---|---|---|---|
| 751.81 | 589.10 | +27.6% | 709.46 | +6.0% | |
| Revenue from operations | 745.99 | 587.36 | +27.0% | 705.36 | +5.8% |
| Other income | 5.82 | 1.74 | +234.5% | 4.10 | +42.0% |
| 65.08 | 51.22 | +27.1% | 99.74 | -34.8% | |
| Profit before tax | 87.58 | 69.65 | +25.7% | 133.74 | -34.5% |
| Finance costs | 10.78 | 21.84 | -50.6% | 7.22 | +49.3% |
| Depreciation | 44.23 | 42.31 | +4.5% | 42.90 | +3.1% |
| Tax expense | 22.50 | 18.43 | +22.1% | 34.00 | -33.8% |
| Net profit margin | 8.66% | 8.69% | -0.04 pp | 14.06% | -5.40 pp |
| EPS, basic (₹) | 15.09 | 11.87 | +27.1% | 23.12 | -34.7% |
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Tax is taxed at the reduced rate under Section 115BAA, which the company has used from FY 2025-26. A one-time deferred tax credit of ₹80.87 crore was recognised in the half year ended 30 Sep 2025 and the year ended 31 Mar 2026, which the filing describes as arising from remeasurement under Section 115BAA.
| Particulars | Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ |
|---|---|---|---|---|---|
| 751.81 | 589.10 | +27.6% | 709.46 | +6.0% | |
| Revenue from operations | 745.99 | 587.36 | +27.0% | 705.36 | +5.8% |
| Other income | 5.82 | 1.74 | +234.5% | 4.10 | +42.0% |
| 64.42 | 51.52 | +25.0% | 99.18 | -35.0% | |
| Profit before tax | 86.92 | 69.95 | +24.3% | 133.18 | -34.7% |
| Finance costs | 10.78 | 21.84 | -50.6% | 7.22 | +49.3% |
| Depreciation | 44.23 | 42.31 | +4.5% | 42.90 | +3.1% |
| Tax expense | 22.50 | 18.43 | +22.1% | 34.00 | -33.8% |
| Net profit margin | 8.57% | 8.75% | -0.18 pp | 13.98% | -5.41 pp |
| EPS, basic (₹) | 14.93 | 11.94 | +25.0% | 22.99 | -35.1% |
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Standalone figures follow the same pattern. Total income rose 27.6% YoY, and net profit rose 25.0%, slower than the consolidated rise of 27.1%. Consolidated net profit of ₹65.08 crore is ₹0.66 crore higher than standalone net profit of ₹64.42 crore.
Standalone profit before tax of ₹86.92 crore is 24.3% higher than a year earlier. Tax expense of ₹22.50 crore is 25.9% of that profit before tax. Other income of ₹5.82 crore is 6.7% of profit before tax.
Net profit fell 35.0% QoQ on standalone figures, against 6.0% growth in total income. The filing gives no reason for the quarter-on-quarter fall.
Inference
The company invested ₹5.31 crore in non-cumulative optionally convertible debentures of Power Producer during the quarter, under a share subscription agreement signed in FY 2025-26. Power Producer is developing a 19.80 MW wind solar hybrid power plant in Gujarat, and under an Energy Supply Agreement the company will purchase a minimum 51% of its power for 25 years. The filing does not say when the plant will start supplying power or whether further funding will be needed.
The company incorporated a wholly owned subsidiary, Epigral Advanced Materials Limited, on 7 Jul 2026 to manufacture chemicals, with an investment of ₹0.01 crore in its equity. The filing reports dividends paid of ₹21.56 crore in the half year, but does not state the dividend declared for the current period or its record date.
Filed with BSE on . Reference: Original filing (PDF)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.
